Fundación CORI

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials

Phase

• Phase 32 trials

Status

• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Celcuity Inc1 trial
• Stemline Therapeutics, Inc.1 trial

Running trials

• Recruiting

  Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

  NCT06757634· Phase 3· Celcuity Inc· Source

  Contact: Nadene Zack, MS

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting

Closed trials

• Completed

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· Phase 3· Stemline Therapeutics, Inc.· Source